ClinicalTrials.gg
Sign In

Thymus Neoplasms clinical trials

The registry lists 45 studies for Thymus Neoplasms across more than 10 countries. 13 are recruiting or about to start. 9 of them are mainly about Thymus Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 2 narrower conditions too, such as Thymoma: 175 studies, 54 open.

Get an email when these change. Save the Thymus Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
18
Recruiting
10
Terminated
6
Active, not recruiting
4
Status unknown
3
Not yet recruiting
2

Phase

Phase 2
17
Phase 1
12
Phase 3
1

Where

United States
28
China
6
Italy
4
France
3
Spain
3
Korea, Republic of
3

Who runs them

National Cancer Institute (NCI) (9) · Samsung Medical Center (2) · M.D. Anderson Cancer Center (2) · Georgetown University (1) · Jonsson Comprehensive Cancer Center (1) · Grupo Espanol de Tumores Neuroendocrinos (1) · Ass. Prof. Jan Nyman (1) · Indiana University School of Medicine (1)

What is being tested here

Drugs under test in Thymus Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ivonescimab101
Imifoplatin101
177Lu-octreotide, DOTA(0)-Tyr(3)-111
AXL/FLT3/VEGFR2 Inhibitor KC1036101
FAPI-46 GA-68001
FAPI-46001
Bintrafusp alfa001
Zamaporvint001
Sunitinib001
Napabucasin001

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open

Coming up

1phase 3 study under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 10 Thymus Neoplasms studies recruiting now, 4 (40%) set no upper age limit and 3 (30%) stop at 75 or younger. 1 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (10%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
101 (10%)1 (10%)
189 (90%)9 (90%)
309 (90%)9 (90%)
409 (90%)9 (90%)
509 (90%)9 (90%)
659 (90%)9 (90%)
759 (90%)9 (90%)
857 (70%)7 (70%)

Across all 45 studies, recruiting or not: 16% stop at 75 or younger and 4% at 65; 7% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 45 of 45. search them.